Literature DB >> 2427248

Stimulation of angiogenesis by adenosine on the chick chorioallantoic membrane.

J W Dusseau, P M Hutchins, D S Malbasa.   

Abstract

The effect of adenosine on the vascular density of the chick chorioallantoic membrane was studied. Elvax polymer pellets containing 0.2-3.0 mg of adenosine were placed on the chorioallantoic membrane of 10-day embryos. Control pellets containing mannitol were placed at least 1 cm away. After 4 days the membrane was formalin-fixed and removed. A thin plastic coverslip, inscribed with concentric circles (4-8 mm in diameter), was placed over the pellet. A vascular density index was estimated at 20 X by counting the number of intercepts between vessels and the inscribed circles. Adenosine stimulated a dose-dependent increase (p less than 0.01) in the vascular density index with the 3-mg pellets inducing a 15% increase. Inosine, a major metabolite of adenosine, did not cause a change in the number of intercepts counted. The adenosine-stimulated increase in vascularity was blocked with 110 micrograms of methyl-isobutyl-xanthine injected daily into the albumin. Partial inhibition was observed with 55 micrograms/day. Methyl-isobutyl-xanthine by itself did not affect the vascular density index. Dipyridamole enhanced adenosine's stimulation of vascular growth an additional 52%. Given alone, however, it had no effect on the membrane's vascularity. These data support an angiogenic role for adenosine. The modest, but consistent, increase in the vascular density index stimulated by adenosine, and the fact that it may be released during tissue hypoxia, is consistent with an hypothesis that this nucleoside plays a modulatory role in vessel proliferation accompanying conditions of long-term hypoxia.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2427248     DOI: 10.1161/01.res.59.2.163

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  22 in total

1.  Endothelial alpha1-adrenoceptors regulate neo-angiogenesis.

Authors:  M Ciccarelli; G Santulli; A Campanile; G Galasso; P Cervèro; G G Altobelli; V Cimini; L Pastore; F Piscione; B Trimarco; G Iaccarino
Journal:  Br J Pharmacol       Date:  2007-12-17       Impact factor: 8.739

2.  Engineering vascularized tissues using natural and synthetic small molecules.

Authors:  Lauren S Sefcik; Caren E Petrie Aronin; Edward A Botchwey
Journal:  Organogenesis       Date:  2008-10       Impact factor: 2.500

Review 3.  Adenosine receptors in wound healing, fibrosis and angiogenesis.

Authors:  Igor Feoktistov; Italo Biaggioni; Bruce N Cronstein
Journal:  Handb Exp Pharmacol       Date:  2009

Review 4.  A systems approach to cancer therapy. (Antioncogenics + standard cytotoxics-->mechanism(s) of interaction).

Authors:  B A Teicher
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

Review 5.  Purinergic signaling in embryonic and stem cell development.

Authors:  Geoffrey Burnstock; Henning Ulrich
Journal:  Cell Mol Life Sci       Date:  2011-01-08       Impact factor: 9.261

Review 6.  A2 adenosine receptors and vascular pathologies.

Authors:  Hillary A Johnston-Cox; Milka Koupenova; Katya Ravid
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-04       Impact factor: 8.311

7.  Embryonic chick muscle produces an FGF-like activity.

Authors:  D S Morris; S J Stock; J C McLachlan
Journal:  Experientia       Date:  1996-08-15

Review 8.  Adenosine and the adaptation to exercise.

Authors:  R E Simpson; J W Phillis
Journal:  Sports Med       Date:  1993-04       Impact factor: 11.136

9.  Evaluation of laser doppler flowmetry for the study of benign and malignant gastric blood flow in vivo.

Authors:  M K Schilling; C Redaelli; H Friess; B Blum; C Signer; C A Maurer; M W Büchler
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

10.  Stimulation of human umbilical vein endothelial cell proliferation by A2-adenosine and beta 2-adrenoceptors.

Authors:  V Sexl; G Mancusi; S Baumgartner-Parzer; W Schütz; M Freissmuth
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.